Alpha 2.0
Login Register
» Authors » P Murchie

P Murchie

Explore the profile of P Murchie including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 294
Followers 0
Related Specialties
Oncology
General Medicine
Pharmacology
Top 10 Co-Authors
A J Lee
N C Campbell
L D Ritchie
S Hall
E A Raja
F M Walter
C R Cardwell
R Robertson
L Samuel
G Ramsay
Published In
Br J Cancer
Br J Dermatol
BMJ
Surgeon
Acta Physiol Scand
Affiliations
Soon will be listed here.
Recent Articles
1.
Assessing the impact of rurality on oesophagogastric cancer survival in the North-East of Scotland- a prospective population cohort study
Griffin F, Hunter R, McCouaig P, Murchie P, Nanthakumaran S, Ramsay G
Surgeon . 2022 May; 21(3):e97-e103. PMID: 35606259
Introduction: Despite advances in oncology therapies and surgical techniques, survival from oesophagogastric cancer remains low. Poorer cancer outcomes and survival for rural dwellers is documented worldwide and has been an...
2.
A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies
McDowell R, Hughes C, Murchie P, Cardwell C
BMC Med . 2021 Jan; 19(1):22. PMID: 33494748
Background: Studies systematically screening medications have successfully identified prescription medicines associated with cancer risk. However, adjustment for confounding factors in these studies has been limited. We therefore investigated the association...
3.
The effect of medications associated with drug-induced pancreatitis on pancreatic cancer risk: A nested case-control study of routine Scottish data
McDowell R, Hughes C, Murchie P, Cardwell C
Cancer Epidemiol . 2021 Jan; 71(Pt A):101880. PMID: 33422975
Background: Inflammation plays a role in pancreatic cancer. Many medications cause pancreatic inflammation, with some leading to a diagnosis of drug-induced pancreatitis (DIP), but few studies have examined these medications...
4.
Analysing the impact of living in a rural setting on the presentation and outcome of colorectal cancer. A prospective single centre observational study
MacVicar E, Ritchie D, Murchie P, Parnaby C, MacKay C, Ramsay G
Surgeon . 2020 Mar; 18(6):354-359. PMID: 32184069
Introduction: Approximately 17% of the Scottish population lives in a remote or rural location. Current research is contradictory as to whether living a rural location leads to poorer outcomes or...
5.
Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma
Murchie P, Masthoff J, Walter F, Rahman K, Allan J, Burrows N, et al.
Trials . 2019 Jun; 20(1):318. PMID: 31159849
Background: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and incidence has increased fivefold in 30 years. Melanoma affects old and young people, with...
6.
A systematic review of the use, quality and effects of pelvic examination in primary care for the detection of gynaecological cancer
Williams P, Bond C, Burton C, Murchie P
J Obstet Gynaecol . 2018 Jun; 38(5):737. PMID: 29944043
Aim: This three part systematic review gathered all the current evidence on the use, quality and effects of pelvic examination (abdominal palpation, bimanual vaginal examination ± visualisation of the cervix)...
7.
Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies
Tran K, McMenamin U, Hicks B, Murchie P, Thrift A, Coleman H, et al.
Aliment Pharmacol Ther . 2018 May; 48(1):55-64. PMID: 29741272
Background: Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are commonly used. PPIs have been shown to promote liver cancer in rats; however, only one study has examined the...
8.
Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries
Torring M, Murchie P, Hamilton W, Vedsted P, Esteva M, Lautrup M, et al.
Br J Cancer . 2017 Aug; 117(6):888-897. PMID: 28787432
Background: The benefits from expedited diagnosis of symptomatic cancer are uncertain. We aimed to analyse the relationship between stage of colorectal cancer (CRC) and the primary and specialist care components...
9.
Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey
Usher-Smith J, Kassianos A, Emery J, Abel G, Teoh Z, Hall S, et al.
Br J Dermatol . 2016 Dec; 176(4):939-948. PMID: 28009060
Background: Melanoma incidence is rising rapidly worldwide among white populations. Defining higher-risk populations using risk prediction models may help targeted screening and early detection approaches. Objectives: To assess the feasibility...
10.
General practice performance in referral for suspected cancer: influence of number of cases and case-mix on publicly reported data
Murchie P, Chowdhury A, Smith S, Campbell N, Lee A, Linden D, et al.
Br J Cancer . 2015 Apr; 112(11):1791-8. PMID: 25880009
Background: Publicly available data show variation in GPs' use of urgent suspected cancer (USC) referral pathways. We investigated whether this could be due to small numbers of cancer cases and...